Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Clinical Trial

Is This Biotech Stock a Rising Star in the Making?

Shares of oncology-focused biotechnology company Sonnet BioTherapeutics (SONN) have plummeted more than 70% in price year-to-date due to its poor financials and the broad-based market sell-off. However, the company is advancing its drug candidates via research breakthroughs, clinical trials, and strategic initiatives. Given the company’s constant progress, can this biotech…

StockNews.com

Needle-free COVID-19 vaccine trial begins on the Sunshine Coast in Australian-first

An Australian-first clinical trial for a new needle-free COVID-19 vaccine has begun on the Sunshine Coast, in good news for those who fear the jab.

ABC News

Teletrial program to deliver specialised health care to thousands of regional and remote Australians

Australians living in regional and remote parts of the country could soon have access to specialised health care for diseases such as cancer as a Queensland-led telehealth program expands nationally.

ABC News

From analysis to the latest developments in health,
read the most diverse news in one place.

Patients receive transfusion of laboratory-grown blood in world-first clinical trial

Volunteers receive a transfusion of blood grown in a laboratory from stem cells of donors to see if it lasts longer than blood donated from a standard transfusion.

ABC News

Verve Therapeutics Crushed By Clinical Hold

The FDA is taking a cautious approach to gene editing clinical trials in the United States, forcing companies to go overseas for early data generation.

The Street

New drug could help tackle 'untreatable' high blood pressure

Researchers said those given it during a clinical trial were found to have significantly lower blood pressure

Wales Online

‘Exciting’ development in tackling untreatable high blood pressure

Those who took a new drug during a clinical trial were found to have significantly lower blood pressure after other traditional medicines had failed.

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Krystal Biotech Needs to Feed the Goldfish in 2023

Development delays across the pipeline risks losing interest on Wall Street, which has the attention span of a goldfish.

The Street

Bristol laboratory runs first clinical trial which could 'revolutionise' treatments for people with blood disorders

Scientists say that if proved safe, manufactured blood cells could revolutionise treatments for people with blood disorders

Bristol Post

World-first transfusions of lab-grown blood cells in huge boost to NHS amid shortage

Two successful clinical trials of lab-grown red blood cells could revolutionise treatments for people with rare blood types amid an NHS shortage

Daily Mirror

Next-Gen Psychedelic Delivers Promising Results For Treatment-Resistant Depression In Phase 2 Clinical Trial

Psychedelics biotech company Biomind Labs Inc. (OTC: BMNDF) has announced positive initial results from part 1 of a Phase 2 clinical trial on its proprietary liquid inhaled formulation of DMT, BMND01, designed for Treatment-Resistant Depression (TRD).

Benzinga

First Take-Home Psychedelics Clinical Trial In North America Will Target PTSD

Vancouver-based psychedelics biopharma company Apex Labs Ltd.

Benzinga

Research: Ultrasound Scan Can Detect Prostate Cancer

Researchers at Imperial College London, University College London and Imperial College Healthcare NHS Trust have found that a new type of ultrasound scan can diagnose most prostate cancer cases with good accuracy in a clinical trial involving 370 men. Read on for details:

Dynamite News

Australian Psychedelics: Incannex Business & Financials, New Research Center For Mushrooms & Eating Disorders

Clinical-stage biopharma company Incannex Healthcare Ltd. (NASDAQ: IXHL) shared its quarterly activities report and appendix 4C for the period ended 30 September 2022, noticeably applying for several U.S.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Atai's Phase 2 Study For Treatment-Resistant Depression Completes Enrollment, Expects Results Soon

Clinical stage psychedelics company atai Life Sciences (NASDAQ: ATAI) and its majority-owned subsidiary Perception Neuroscience completed patient enrollment for their Phase 2a clinical trial assessing the safety and efficacy of a single intravenous infusion (IV) dose of proprietary R-ketamine PCN-101 for patients

Daily Mirror

'Clinical trials on computers cut costs and reduce need for human volunteers'

Miriam Stoppard discusses the rising use of computer simulations in clinical trials which drastically cuts costs and reduces the need to use humans or animals

Benzinga

Small Pharma's Q2 2023 Financial Results, 'Ultra Short-Acting Psychedelic Program' Underway

Small Pharma Inc. (OTCQB: DMTTF), a biotech company developing short-acting psychedelic-assisted therapies for diverse mental health disorders, reported its financial results for the three and six months ended August 31, 2022. For the period numbers show:

Manchester Evening News

The miracle tablet that has kept a beloved granddad's deadly prostate cancer at bay for a DECADE

A biopsy showed Jim had stage 4 - the most advanced stage - prostate cancer. It had spread to the lymph nodes and wasn’t curable, but then Jim was placed on an experimental trial

Get all your
news in one place.

100’s of premium titles.
One news app.

The Street

Dice Therapeutics Aces Psoriasis Study and Stock Surges. What's Next?

Dice Therapeutics shares leaped on positive data for its lead drug candidate. What comes next?

Los Angeles Times

Three years after clinical trial, ketamine provides hope for severely depressed

LOS ANGELES -- Patients arriving at Dr. Philip O'Carroll's Newport Beach office for their first ketamine treatment are in pain and often lost. They have visited other doctors, tried other solutions and are ready for what is considered a last resort.

Benzinga

CBD Oil On Behavioral Disturbances In Dementia Patients, Positive Clinical Trial

In a recent study published in Frontiers in Medicine, researchers showed that "almost 90% of patients with dementia suffer from some type of neurobehavioral symptom, and there are no approved medications to addr

Axios

Another prospect for an Alzheimer's drug renews cost concerns

But positive clinical trial results also renew the hopes of millions of seniors.

The Independent UK

‘Major breakthrough’ as dementia drug found to ‘slow cognitive decline’

The new clinical trial found that there was a significant reduction in the decline in memory and thinking usually seen in early-stage patients.

Daily Record

Courageous Lanarkshire teen who survived leukaemia thanks to a clinical trial pursues nursing dream

Katie Currie, 19, who is in remission from the disease, has been chosen to help launch Childhood Cancer Awareness month in Scotland this September.

Daily Mirror

'I wouldn't be here today if my mum wasn't always looking for new cancer treatments'

Joan McFadden speaks to a mum-daughter duo who have discovered the importance of clinical research trials for those living with cancer. Here, they tell their story

1 … 6 7 8 9

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Imperial College London

University College London

122 stories

Alzheimer Research UK

NHS Blood and Transplant

65 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.